GoAI
Get started
Lumexa Imaging Holdings, Inc. Common Stock logo

Lumexa Imaging Holdings, Inc. Common Stock

LMRI

NASDAQHealthcareMedical - Devices

Open in GoAI

Previous close

$12.42

+$0.74 · +6.34%

Aug 21, 4:00 PM ET

LMRI company overview

Regular session · ET · Market data may be delayed.

Company profile

Company website

Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States. These facilities deliver a comprehensive range of outpatient medical imaging solutions, encompassing advanced procedures like Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans, in addition to standard diagnostic and screening services such as X-rays, ultrasounds, and mammography. The company was founded in 2018 and its primary base of operations is in Raleigh, North Carolina.

Industry
Medical - Devices
Sector
Healthcare
Headquarters
US
CEO
Caitlin Zulla
Listed since
Dec 11, 2025
Employees
5,000

Market position

Day range

Current $12.42

52-week range

Current $12.42

Open
$11.74
Previous close
$11.68
Volume
487.23K
0.65× average
Average volume
750.34K
Average daily volume
Market cap
1.19B USD
Beta
1.01
Market reference 1
50-day average
$11.0892
+12.00% above average
200-day average
$11.9563
+3.88% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
2.22B USD
P/E (TTM)
-29.94×
P/B (TTM)
1.94×
P/S (TTM)
1.16×
EV / EBITDA
15.64×
Earnings yield
-3.59%
Free cash flow yield
-0.49%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
11.65%
Operating margin
1.12%
Net margin
-3.10%
Return on equity
-8.04%
Return on assets
-2.67%
Return on invested capital
1.65%

Financial health

Debt / equity
1.59×
Current ratio
1.27×
Altman Z-score
0.83
Piotroski F-score
6 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends14%4%-6%-16%Gross margin, FY2023: 10.57%Gross margin, FY2024: 10.15%Gross margin, FY2025: 11.45%Operating margin, FY2023: 2.40%Operating margin, FY2024: 5.82%Operating margin, FY2025: 2.61%Net margin, FY2023: -13.06%Net margin, FY2024: -9.92%Net margin, FY2025: -4.60%FY2023FY2024FY2025
Gross margin FY2023 10.57%. Gross margin FY2024 10.15%. Gross margin FY2025 11.45%. Operating margin FY2023 2.40%. Operating margin FY2024 5.82%. Operating margin FY2025 2.61%. Net margin FY2023 -13.06%. Net margin FY2024 -9.92%. Net margin FY2025 -4.60%.

Income trends

Revenue

1.02B USD+7.82%

Operating income

26.73M USD-51.61%

Net income

−47.1M USD+49.94%
Income trends across reported periods1.14B USD679.49M USD221.37M USD−236.76M USDRevenue, FY2023: 935.93M USDRevenue, FY2024: 948.87M USDRevenue, FY2025: 1.02B USDOperating income, FY2023: 22.45M USDOperating income, FY2024: 55.24M USDOperating income, FY2025: 26.73M USDNet income, FY2023: −122.23M USDNet income, FY2024: −94.1M USDNet income, FY2025: −47.1M USDFY2023FY2024FY2025
Revenue FY2023 935.93M USD. Revenue FY2024 948.87M USD. Revenue FY2025 1.02B USD. Operating income FY2023 22.45M USD. Operating income FY2024 55.24M USD. Operating income FY2025 26.73M USD. Net income FY2023 −122.23M USD. Net income FY2024 −94.1M USD. Net income FY2025 −47.1M USD.
Metric (USD)FY2025FY2024FY2023
Revenue1.02B USD948.87M USD935.93M USD
Cost of goods sold905.9M USD852.61M USD836.96M USD
Gross profit117.19M USD96.26M USD98.97M USD
Selling, general, and administrative90.45M USD70.36M USD55.17M USD
Operating expenses90.45M USD41.02M USD76.52M USD
Interest expense118.54M USD136.03M USD141.69M USD
Depreciation and amortization55.39M USD57.16M USD72.14M USD
Operating income26.73M USD55.24M USD22.45M USD
Net income−47.1M USD−94.1M USD−122.23M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
50%
2 beats, 2 misses, 0 met estimates
Average EPS surprise
-237.99%
4 comparable reports
Latest EPS result
0.2
Estimate 0.15 · Beat by 34.86%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.250.02-0.2-0.43Q4 '25MissQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q4 2025, reported Dec 3, 2025: actual -0.035, estimate 0.046, surprise -176.82%, Miss. Q1 2026, reported Mar 26, 2026: actual -0.38, estimate 0.05, surprise -860.00%, Miss. Q2 2026, reported May 12, 2026: actual 0.18, estimate 0.12, surprise +50.00%, Beat. Q3 2026, reported Aug 12, 2026: actual 0.2, estimate 0.148, surprise +34.86%, Beat. Q4 2026, reported Nov 11, 2026: actual —, estimate 0.19, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates280.99M266.9M252.81M238.72MQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q4 2025, reported Dec 3, 2025: actual 260.08M USD, estimate 261.17M USD, surprise -0.42%, Miss. Q1 2026, reported Mar 26, 2026: actual 267.73M USD, estimate 261.17M USD, surprise +2.51%, Beat. Q2 2026, reported May 12, 2026: actual 252.54M USD, estimate 249.52M USD, surprise +1.21%, Beat. Q3 2026, reported Aug 12, 2026: actual 264.16M USD, estimate 263.12M USD, surprise +0.40%, Beat. Q4 2026, reported Nov 11, 2026: actual —, estimate 270.18M USD, surprise —, Comparison unavailable.

LMRI news

seekingalpha.com

Lumexa Imaging Holdings, Inc. (LMRI) Q2 2026 Earnings Call Transcript

Lumexa Imaging Holdings, Inc. (LMRI) Q2 2026 Earnings Call Transcript

Read source
marketbeat.com

Lumexa Imaging Q2 Earnings Call Highlights

Lumexa Imaging NASDAQ: LMRI reported second-quarter revenue growth, higher advanced-imaging volumes and a return to profitability, while narrowing its full-year adjusted EBITDA outlook and reiterating revenue and…

Read source
globenewswire.com

Lumexa Imaging Announces Second Quarter 2026 Results

RALEIGH, N.C., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today reported results for the second quarter ended June 30, 2026, and…

Read source
globenewswire.com

Lumexa Imaging Announces Second Quarter 2026 Earnings Conference Call Date

RALEIGH, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its second quarter 2026 financial and…

Read source
zacks.com

4 Medical Products Stocks Poised to Win Despite Industry Headwinds

Terumo, QuidelOrtho, Lumexa Imaging and BrainsWay are tackling industry headwinds through innovation, pricing and execution as healthcare demand stays resilient.

Read source
zacks.com

Wall Street Analysts Think Lumexa (LMRI) Could Surge 44.08%: Read This Before Placing a Bet

The mean of analysts' price targets for Lumexa (LMRI) points to a 44.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings…

Read source

LMRI peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding LMRI

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
7.92M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
5.95M
Weight
0.01%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96+0.77%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
2.98M
Weight
0.00%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
iShares Russell 2000 Value ETF logoiShares Russell 2000 Value ETFIWN
Market value
2.1M
Weight
0.01%
AUM
14.66B USD
Expense ratio
0.24%
Price / 1D
$224.81+0.45%
Schwab U.S. Small-Cap ETF logoSchwab U.S. Small-Cap ETFSCHA
Market value
1.36M
Weight
0.01%
AUM
23.1B USD
Expense ratio
0.03%
Price / 1D
$34.83+0.52%
F/M Emerald Life Sciences Innovation ETF logoF/M Emerald Life Sciences Innovation ETFLFSC
Market value
1.2M
Weight
0.93%
AUM
74.65M USD
Expense ratio
0.54%
Price / 1D
$47.7953+0.83%
Vanguard Russell 2000 ETF logoVanguard Russell 2000 ETFVTWO
Market value
1.1M
Weight
0.01%
AUM
17.4B USD
Expense ratio
0.06%
Price / 1D
$121.25+0.74%
Vanguard Health Care ETF logoVanguard Health Care ETFVHT
Market value
758.54K
Weight
0.00%
AUM
20.9B USD
Expense ratio
0.09%
Price / 1D
$327.7+1.24%

Continue in GoAI

Research LMRI

research.disclaimer